Dedifferentiated Liposarcoma

general

An atypical lipomatous tumor/well differentiated liposarcoma that shows progression to a usually non-lipomatous, high grade sarcoma. The non-lipomatous sarcoma component may be present in the primary lesion or at the site of recurrence.

66

Centers

168

Active Trials

$8.3B

Cancer Funding

Specific Cancer Types(3)

Top Centers for Dedifferentiated Liposarcoma(66)

Ranked by research excellence score (trials · grants · publications). Methodology →

#CenterScore
1
NCI Comprehensive
High-Volume Research Center
89.1
2
NCI Comprehensive
Active Research Program
67.9
3
NCI Comprehensive
49.7
4
NCI Comprehensive
49.7
549.7
649.7
7
NCI Comprehensive
49.7
8
NCI Comprehensive
49.7
9
NCI Comprehensive
49.7
10
NCI Comprehensive
49.7
1149.7
12
NCI Comprehensive
49.7
13
NCI Comprehensive
49.7
14
NCI Comprehensive
49.7
15
NCI Comprehensive
49.7
1649.7
1749.7
18
Cedars-Sinai CancerLos Angeles, CA
49.7
1949.7
2049.7
21
Fox Chase Cancer CenterPhiladelphia, PA
NCI Comprehensive
49.7
2249.7
2349.7
2449.7
2549.7
2649.7
2749.7
28
NCI Comprehensive
29
NCI Comprehensive
30
NCI Comprehensive
31
NCI Comprehensive
32
NCI Comprehensive
33
34
35
36
Masonic Cancer CenterMinneapolis, MN
NCI Comprehensive
37
NCI Comprehensive
38
NCI Comprehensive
39
NCI Comprehensive
40
NCI Clinical
41
42
NCI Comprehensive
43
NCI Comprehensive
44
45
NCI Comprehensive
46
NCI Comprehensive
47
NCI Comprehensive
48
49
50
51
NCI Comprehensive
52
NCI Comprehensive
53
54
55
56
57
NCI Basic_laboratory
58
59
60
61
62
63
64
65
66

Research tier badges reflect trial volume, NIH grant funding, and publication impact — not clinical outcomes or patient satisfaction. Learn about our methodology →